pragma.vision Your technology observatory

Verification register Bio, Health & Neuro

Living definition

What is CPTX2309 (Capstan in vivo CAR-T)?

Vaccines & Immunotherapy Bio, Health & Neuro

As of
2026-07-19
Revision
2026-07-19.2
Method
v1.3.0

Definition

The term, in context

AI-assisted draft · approved dataset

CPTX2309 is an experimental therapy that delivers CAR-T instructions directly inside a patient’s body using a lipid nanoparticle, rather than engineering the patient’s immune cells outside the body first.

Live readiness status

Status as of the current dateline

AI-assisted assembly · derived results

As of 2026-07-19, verified readiness is 20 (claimed 30, reported 27, gap 10) — Strong evidence strength; current signals suggest Too early to adopt.

The readiness fact belongs to the canonical Readiness Verdict for CPTX2309 (Capstan in vivo CAR-T).

Dataset approval

Human editorial release

pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)

Dataset
2026-07-19.2
Hash
sha256:5b6f2a037b720dbb2ee4216d94ab16dcb623c06c65387010d64145dfda66d13d
Approved
2026-07-19

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.